Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in Oman.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Atopic Dermatitis
  • Diabetes
  • Asthma
  • Nasal Polyps
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Pertussis & Polio
    • Meningitis
  • Multiple Sclerosis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
  • Atopic Dermatitis
  • Rare Diseases
  • Nasal Polyps
PRODUCTS
  • PRODUCTS
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Clexane®
  • Plavix®
  • Apidra®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
  • Praluent®
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
  • Lantus®
  • Aubagio®
  • Lemtrada®
  • Amaryl®
Home | go to homepage
Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Atopic Dermatitis
  • Diabetes
  • Asthma
  • Nasal Polyps
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Pertussis & Polio
    • Meningitis
  • Multiple Sclerosis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
  • Atopic Dermatitis
  • Rare Diseases
  • Nasal Polyps
PRODUCTS
  • PRODUCTS
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Clexane®
  • Plavix®
  • Apidra®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
  • Praluent®
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
  • Lantus®
  • Aubagio®
  • Lemtrada®
  • Amaryl®
  • LOGIN
  • REGISTER
  • SEARCH
    • Home
    • Science
    • Cardiovascular
    • Dyslipidemia

    Dyslipidemia

    Learn about the latest trends, discover events and innovations in the changing world of dyslipidemia disease.

    Science in Dyslipidemia Disease

    Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you

    ODYSSEY Outcomes

    Odyssey Outcomes - Mortality

    NEJM Odyssey Outcomes

    Odyssey Outcomes - CABG Results

    Odyssey Outcomes - PVD Results

    Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

    Odyssey Outcomes - PVD Sub-analysis

    ESC/EAS 2019 International Guidelines

    Odyssey Outcomes - Elderly Patients Results

    Odyssey Outcomes - Total Events Results

    Odyssey Outcomes - DM sub-analysis

    Odyssey Outcomes - Total Events Analysis

    SEE EVERYTHING

    Inspiration and innovation

    Get inspired and stay at the forefront of innovation with the following resources

    EAS guidance regarding combining lipid-modifying therapy

    Lp(a) and PCSK9 inhibition in nominally controlled LDL-C

    The Role of the Patient in Achieving LDL-C Target

    Treating to target in clinical practice: Why is it important to achieve recommended LDL-C levels?

    SEE EVERYTHING

    Events

    Stay up to date and register for the latest events and view webinar recordings.

    24:30

    Dyslipidemia Webinars: Optimizing Dyslipidemia management​

    Dyslipidemia Webisodes: Mortality data with Prof. Tunon

    Dyslipidemia Expert Exchange: Best practice approaches in dyslipidemia management

    SEE EVERYTHING
    Home | go to homepage

    SANOFI, Level 3, One JLT, Jumeirah Lake Towers (JLT), DMCC, PO Box 53899, Dubai, UAE |

    Tel.: +971 4 550 3600 | Fax: +971 4 5521050

    For further Medical Information:

    please contact: +971 565776791 or Email: medical-information.gulf@sanofi.com

    To report an adverse event:

    please call: +971 561747001 or Email: Gulf.pharmacovigilance@sanofi.com

    To report any product technical complaints, kindly contact: Email: quality.greatergulf@sanofi.com

     

    MAT-OM-2100060/V2/Nov 2021

    • Legal notice
    • Cookie policy
    • Privacy policy
    • Sitemap
    • Change country

    YOU WILL NOW BE LEAVING THE SITE

    By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
    Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

    Continue
    This website is intended exclusively for healthcare professionals residing and/or working in Oman.
     
    Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.